REPORT ID 6307

Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

Publish Date
25-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aslan Pharmaceuticals Pte Ltd
    Boehringer Ingelheim GmbH
    GamaMabs Pharma SA
    Hanmi Pharmaceuticals Co Ltd
    Jiangsu Kanion Pharmaceutical Co Ltd
    Minerva Neurosciences Inc
    Pfizer Inc
    Puma Biotechnology Inc
    Shanghai Fosun Pharmaceutical (Group) Co Ltd
    XuanZhu Pharma Co Ltd
    Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Afatinib Dimaleate
    Dacomitinib
    Neratinib
    Neucardin
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017
1 Receptor Tyrosine Protein Kinase Targeted Drugs Overview
    1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
    1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs by Product Category
        1.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Afatinib Dimaleate
        1.2.4 Dacomitinib
        1.2.5 Neratinib
        1.2.6 Neucardin
        1.2.7 Others
    1.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Others
    1.4 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
        1.4.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
        1.5.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs (Volume) by Application
    2.4 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)

3 China Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    3.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        3.1.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    3.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    3.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    4.1 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        4.1.1 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    4.2 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    4.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

5 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    5.1 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    5.3 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

6 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

7 India Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    7.1 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        7.1.1 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    7.2 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    7.3 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

8 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

9 Australia Receptor Tyrosine Protein Kinase Targeted Drugs (Volume, Value and Sales Price)
    9.1 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
        9.1.1 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price Trend (2012-2017)
    9.2 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Type
    9.3 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Players/Suppliers Profiles and Sales Data
    10.1 Aslan Pharmaceuticals Pte Ltd
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Boehringer Ingelheim GmbH
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 GamaMabs Pharma SA
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Hanmi Pharmaceuticals Co Ltd
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Jiangsu Kanion Pharmaceutical Co Ltd
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Minerva Neurosciences Inc
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Pfizer Inc
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Puma Biotechnology Inc
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 XuanZhu Pharma Co Ltd
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Zensun (Shanghai) Sci & Tech Co Ltd

11 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
    11.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Dr